Aayush Wellness enters ₹18,913 Cr respiratory market

Aayush Wellness Limited has launched "Lung Care Tablets" to tap into India's ₹18,913 crore respiratory healthcare market. This move expands the company's focus on preventive wellness and nutraceutical solutions, addressing health concerns related to smoking, air pollution, and environmental exposure. The Indian respiratory healthcare segment saw a 10% year-on-year growth in sales, reaching ₹18,912.64 crore in 2025. Aayush Wellness aims to build a differentiated position in the preventive respiratory-wellness category with its science-backed formulation containing N-Acetyl Cysteine, Vasaka Extract, and other immune-supportive ingredients.